The
Cannabis Partnership Congress brings together all of the key stakeholders in a collaborative environment to face the scientific, medicinal, and governmental challenges of cannabis-based product development. Despite recent changes in state policy and with the increasing rate of cannabis use and its implications for health, the federal government has yet to legalize cannabis. When facing the continued restrictions on research into the health benefits of cannabis, what strategies must pharma companies follow to bring these therapeutics to market?
Clinical research with cannabis needs special approval from FDA, while obtaining the plants themselves involves a separate time-consuming process through NIDA. The Cannabis Partnership Congress helps you navigate all of these regulatory and development challenges.
Top Reasons to Attend
- Review standards, current regulatory hurdles, and upcoming legislation
- Understand the science and economics surrounding the extraction and QC manufacturing
- Recognize the patient role for effective cannabidiol research and approvals
- Discover how to improve the quality and efficiency of data integrity in clinical trials
Speakers
- Verónica Arroyave, Sr. Director, Global Health Programs, PARTNERSHIP FOR QUALITY MEDICAL DONATIONS
- Dr. Bruno Battistini, President, CEO and Scientific Director, NEW BRUNSWICK HEALTH RESEARCH FOUNDATION
- Bruce Bloom, CEO, CURES WITHIN REACH
- Jerry Bryant, Managing Member, VYRIPHARM BIOPHARMACEUTICAL
- Dr. Guy Chamberland, M.Sc., Ph.D., Master Herbalist, Chief Scientific Officer and Regulatory Affairs, TETRA BIO-PHARMA
- Nial Chase DeMena, CEO, MANNA MOLECULAR SCIENCE
- Lezli Engelking, President and Founder, FOCUS
- Brian Fisher, Vice President of Operations and Corporate Partnerships, STURGE-WEBER FOUNDATION
- Elias Jackson, Ph.D., CEO, VYRIPHARM BIOPHARMACEUTICAL
- Darshan Kulkarni, FDA Regulatory and Compliance Attorney, THE KULKARNI LAW FIRM
- Alice Mead, Vice President, U.S. Professional Relations, GREENWICH BIOSCIENCES
- Dean Petkanas, Chief Medical Officer, KANNALIFE SCIENCES
- Christina DiArcangelo Puller, CEO and Founder, AFFINITY BIOCEUTICALS
- Barbara Read, Vice President of Sales and Marketing, LIFESCRIPT
- Mark Reichman, EVP, Client Services Director, GUIDEMARK HEALTH, Cannabis Patient Advocate
- Jeremy Unruh, General Counsel and Chief Compliance Officer, PHARMACANN LLC
- Sara Jane Ward, Ph.D., Assistant Professor, CENTER FOR SUBSTANCE ABUSE RESEARCH, DEPARTMENT OF PHARMACOLOGY, LEWIS KATZ SCHOOL OF MEDICINE, TEMPLE UNIVERSITY
Please fill in your name and email to receive the conference agenda of this event.
Conference Day One - Monday March 12, 2018
Conference Day Two - Tuesday March 13, 2018
The agenda is available as PDF under downloads at the right side of the page.
Venue
Hilton San Francisco Airport Bayfront
600 Airport Blvd, 94010
Burlingame, San Francisco, CA, USA
Who Should Attend
This conference is of interest to professionals from pharmaceutical, biotechnology and medical device companies, Non-Profits, Patient Advocacy Groups and Academics with responsibilities in the following functions:
- Cannabis
- Cannabinoid Science
- Strategic Partnerships
- Program and Pharmaceutical Portfolio Development
- Translational Medicine
- Medical Science Liaisons
- Asset Management
- Pre-Clinical Staging Development
- Source Management
- Research and Development
- Regulatory Affairs
- Patient Advocacy and Networks
- Legislative Health Aids
- Strategic Partnerships
- Cannabis Clinical Trial Management/Operations
- Clinical Research
- Medical/Clinical Affairs
- Personalized Medicine
- Patient Advocacy/Access
- Commercial Operations
- Lab Management
- Toxicology
Additionally, this event is for those in the public and private foundations, military support groups, university research, investors in the cannabis sector, economics surrounding the extraction and quality control manufacturing, This event is geared perfectly to bring together the cross-functional synergies for success in the Cannabidiol market place.
Venue
Hilton San Francisco Airport Bayfront600 Airport Boulevard
Burlingame, CA 94010
The Hilton San Francisco Airport Bayfront is conveniently located four miles from SFO Airport and offers Guests a complimentary airport shuttle. Find guest rooms and Executive rooms with views of the San Francisco Bay and downtown skyline. Enjoy the convenience of on-site dining, 11,000 sq. ft. of flexible event space and pet-friendly amenities. Stay in shape with our fitness center, indoor heated pool and scenic walking/jogging path along the San Francisco Bay.
To make reservations, please call the Hilton Reservations number 1-800-HILTONS (445-8667) and request the negotiated rate for ExL’s March Events. To make reservations online
Click HereThe group rate is available until February 20, 2018. Please book your room early, as rooms available at this rate are limited.
